Whalegun
Home

Neurocrine Biosciences NBIX spent $940K on lobbying in Q2 2026 · Medicare, Health Issues and 2 more issues

Trade details

Type
Lobbying report
Amount
$940,000
Quarter
Q2 2026
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
26/07/20

Up 0.0% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Neurocrine Biosciences's other lobbying reports

Neurocrine Biosciences NBIX spent $940K on lobbying in Q2 2026 · Medicare, Health Issues and 2 more issues | Whalegun